Antineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyChemoradiotherapyRadiotherapy DosageChemotherapy, AdjuvantCisplatinRadiotherapy, Intensity-ModulatedRadiotherapy, ConformalDose FractionationEsophagitisTreatment OutcomeRadiotherapyCarboplatinNeoplasm StagingLung NeoplasmsMucositisAntineoplastic AgentsRadiation PneumonitisRadiation InjuriesDisease-Free SurvivalProton TherapyCarcinoma, Non-Small-Cell LungNasopharyngeal NeoplasmsFluorouracilSurvival AnalysisCarcinoma, Squamous CellThoracic NeoplasmsSurvival RateRadiotherapy, High-EnergyPaclitaxelRadiotherapy, AdjuvantDose-Response Relationship, RadiationNeoadjuvant TherapyOrgans at RiskEtoposideHead and Neck NeoplasmsDrug Administration ScheduleNeoplasm Recurrence, LocalAnus NeoplasmsPrognosisFollow-Up StudiesEsophageal NeoplasmsUterine Cervical NeoplasmsKaplan-Meier EstimateCyclophosphamideDoxorubicinRetrospective StudiesBrachytherapyRadiotherapy Planning, Computer-AssistedNeoplasm MetastasisAdenocarcinomaTreatment FailureCarcinomaBreast NeoplasmsCarcinoma, Small CellMethotrexateInduction ChemotherapyVinblastineTaxoidsRemission InductionDeoxycytidineAntimetabolites, AntineoplasticIfosfamideDrug Resistance, NeoplasmNeoplasmsOrganoplatinum CompoundsBleomycinTime FactorsAntineoplastic Agents, AlkylatingAnthracyclinesSalvage TherapyCytarabineChemotherapy, Cancer, Regional PerfusionOvarian NeoplasmsNeutropeniaAntineoplastic Agents, PhytogenicProspective StudiesVomitingTesticular NeoplasmsNauseaTransplantation, AutologousLymphoma, Non-HodgkinDacarbazineHodgkin DiseaseColorectal NeoplasmsDose-Response Relationship, DrugBrain NeoplasmsAntibiotics, AntineoplasticClinical Trials as TopicCamptothecinLeukopeniaCarmustineMitomycinGranulocyte Colony-Stimulating FactorInfusions, IntravenousNeoplasms, Germ Cell and EmbryonalInfusions, Intra-ArterialLomustineBone NeoplasmsTegafur